Moxibustion as an Adjuvant Therapy for Chronic Kidney Disease: A Systematic Review and Meta-Analysis of 23 Randomized Controlled Trials.

ABSTRACT:

Objective

This systematic review aims to investigate the efficacy and safety of moxibustion for chronic kidney disease (CKD).

Methods

Nine databases were searched to identify relevant evidence up to March 8, 2020. Randomized controlled trials (RCTs) that tested moxibustion + basic treatments versus basic treatments alone for patients with CKD and reported, at least, one of the outcomes of interest were included. In the meta-analyses, the mean differences (MDs) and 95% confidence intervals (CIs) were used to measure the effect size.

Results

Twenty-three RCTs (n = 1571) with a moderate to high risk of bias were included. The pooled estimates showed that compared with the controls, patients after moxibustion had a significant reduction in serum creatinine (MD -17.

SUBMITTER: Zhou X 

PROVIDER: S-EPMC7641698 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature